Hepatocellular carcinoma occurs frequently and early after treatment in HCV genotype 3 infected persons treated with DAA regimens

BACKGROUND: There are conflicting data regarding the risk of hepatocellular carcinoma (HCC) after direct-acting antiviral agent (DAA) treatment. Risk of HCC in HCV genotype-3 infected persons after DAA therapy is not well known. METHODS: We prospectively studied HCV infected persons initiated on a D...

Descripción completa

Detalles Bibliográficos
Autores principales: Tayyab, Ghias Un Nabi, Rasool, Shafqat, Nasir, Bilal, Rubi, Ghazala, Abou-Samra, Abdul-Badi, Butt, Adeel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137260/
https://www.ncbi.nlm.nih.gov/pubmed/32252635
http://dx.doi.org/10.1186/s12876-020-01249-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137260/
https://www.ncbi.nlm.nih.gov/pubmed/32252635
http://dx.doi.org/10.1186/s12876-020-01249-4

Ejemplares similares